The economics of treating stroke as an acute brain attack.
Currently, treatments for ischemic stroke focus on restoring or improving perfusion to the ischemic area using thrombolytics. The increased hospitalization costs related to thrombolysis are offset by a decrease in rehabilitation costs, for a net cost savings to the healthcare system. However, early treatment is essential. The benefit of thrombolysis is time-dependent but only a very small proportion of patients, 2%, are presently being treated with tPA. In the United States, if the proportion of all ischemic stroke patients that receive tPA were increased to 4, 6, 8, 10, 15, or 20%, the realized cost saving would be approximately $ 15, 22, 30, 37, 55, and 74 million, respectively. Being so, efforts should be made to educate the public and paramedics regarding early stroke signs. Furthermore, additional acute stroke therapy training programs need to be established for emergency departments. Finally, hospital systems need to be re-engineered to treat patients as quickly as possible in order to optimize thrombolytic benefit as well as maximize cost-effectiveness.
Center for Brain and Nervous System Disorders, Genolier Swiss Medical Network, Clinique Valmont, Glion/Montreux, Switzerland. jbogousslavsky@valmontgenolier.ch
Julien
J
Bogousslavsky
Maurizio
M
Paciaroni
D004493:Education; D006801:Humans; D012046:Rehabilitation / Q000191:economics*; D020521:Stroke / Q000191:economics* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000191:economics*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000191:economics / Q000627:therapeutic use; D014481:United States
D010959:Tissue Plasminogen Activator